The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

Shares of Vertex Pharmaceuticals Inc. VRTX advanced 1.11% to $491.64 Wednesday, on what proved to be an all-around favorable ...

Buy Here: <a href=" The Seasonic Vertex GX-1200 Power Supply! Our Merch: <a href=" CONNECT WITH US! Facebook: <a href=" ...

Vertex Pharmaceuticals demonstrates resilience with robust CF franchise, new approvals, and diversification efforts. Read why ...

Jones Financial Companies Lllp boosted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by ...

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

What's considered excellent revenue growth depends on the industry. With that context in mind, consider that Eli Lilly's ...

Rouse had presented with symptoms including intense swelling in her legs that she originally thought could be linked to her ...

Vertex Pharma (VRTX) stock slips as UnitedHealth (UNH) offers its pain drug Journavx Tier 3 coverage, setting a rivalry with ...

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success ...

Trinasolar has supplied 22MW of its Vertex modules and Vanguard 1P smart tracking systems for the Valcasado solar park in the ...